Jump to content
  • Sign Up
0
Scott Adams

ImmusanT Raises $20M to Advance Vaccine for Celiac Disease - Becker's ASC Review

Rate this topic

Recommended Posts

ImmusanT Raises $20M to Advance Vaccine for Celiac Disease

Becker's ASC Review

ImmusanT, a biotechnology company, raised $20 million in funding from Vatera Healthcare Partners, a venture capital firm focusing on biopharmaceutical firms, for the development of a vaccine and diagnostic tool for celiac disease, according to a news ...

View the full article

Share this post


Link to post
Share on other sites

Create an account or sign in to comment

You need to be a member in order to leave a comment

Create an account

Sign up for a new account in our community. It's easy!

Register a new account

Sign in

Already have an account? Sign in here.

Sign In Now
0

×